Home
Conditions
Leukemia, B-Cell

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,389 public trials 159 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies

NCT01947140

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +44 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Columbia University Irving Medical Center New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Unrelated Donor Stem Cell Transplantation

NCT01364363

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Anemia, +47 more
Locations: Scripps Green Hospital La Jolla, California, United States

View Trial Details

Completed

Nonmyeloablative Allogeneic Transplant

NCT01272817

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adenocarcinoma, +91 more
Locations: Scripps Green Hospital La Jolla, California, United States

View Trial Details

Completed

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT01647971

Conditions: B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +33 more
Locations: TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States

TG Therapeutics Investigational Trial Site Jonesboro, Arkansas, United States

TG Therapeutics Investigational Trial Site Athens, Georgia, United States

TG Therapeutics Investigational Trial Site Macon, Georgia, United States

View Trial Details

Completed

Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies

NCT02556931

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +51 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Ublituximab + Ibrutinib in Select B-cell Malignancies

NCT02013128

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations: TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States

TG Therapeutics Investigational Trial Site Tucson, Arizona, United States

TG Therapeutics Investigational Trial Site Santa Barbara, California, United States

TG Therapeutics Investigational Trial Site Boulder, Colorado, United States

View all 18 locations

View Trial Details

Completed

Study of Immunotherapy in Combination With Ublituximab and Umbralisib in Patients With Relapsed-refractory CLL or Richter's Transformation

NCT02535286

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: TG Therapeutics Investigational Trial Site New York, United States

TG Therapeutics Investigational Trial Site Durham, North Carolina, United States

TG Therapeutics Investigational Trial Site Philadelphia, Pennsylvania, United States

TG Therapeutics Investigational Trial Site Seattle, Washington, United States

View Trial Details

Completed

A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice

NCT03425591

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations: Paris, France

View Trial Details

Completed

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia

NCT00053157

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, Chronic Disease, +55 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis

NCT02065154

Conditions: Allogeneic Transplant, Anemia, Anemia, Aplastic, +31 more
Locations: UAB Bone Marrow Transplantation and Cellular Therapy Program Birmingham, Alabama, United States

View Trial Details

Leukemia, B-Cell

Leukemia, B-Cell trial results

Related conditions